WLWenting Liu

Wenting Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenting Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Fen Fu

    The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330000, China

    2 shared publications
  • Hengyi Xu

    State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China

    2 shared publications
  • Ling Chen

    The Second Affiliated Hospital of Nanchang University, Nanchang 330000, PR China; State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, PR China

    2 shared publications
  • Bei Zhao

    Traditional Chinese Medicine Department, Duchang County People’s Hospital, Jiujiang, China

    1 shared publication
  • Haifang Wu

    The Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, China

    1 shared publication
  • Jia Huang

    Reproductive Health Department, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, China

    1 shared publication

Latest Publications

  • Open Access

    Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression

    by Lu Zhao, Jia Huang, Wenting Liu, Xiaoyan Su, Bei Zhao, Xianggang Wang, Xiaoju He

    Purpose: The present study aims to determine the molecular mechanism mediated by RAD51 antisense RNA 1 (RAD51-AS1) in ovarian cancer (OvCA). Methods: The data associated with RAD51-AS1 in OvCA were obtained from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. Relative expression of RAD51-AS1 was detected. Determination of cell proliferation, metastasis, and invasion was performed by cell counting, colony formation, would-healing, and transwell invasion assays. Protein levels were detected by western blotting. The molecular mechanism mediated by RAD51-AS1 was predicted by bioinformatics analysis and verified by dual-luciferase reporter assays. Subcutaneous tumorigenesis models were used to confirm the function of RAD51-AS1 in vivo. Results: Data from TCGA and GEO showed that RAD51-AS1 was associated with poor prognosis in OvCA patients and DNA repair, cell cycle, focal adhesion, and apoptosis in SKOV3.ip cells. High levels of RAD51-AS1 were detected in OvCA cells. Overexpressing RAD51-AS1 enhanced the proliferative, invading, and migratory capabilities of OvCA cells in vitro while silencing RAD51-AS1 exhibited the opposite effects. Mechanically, RAD51-AS1 elevated eukaryotic initiation factor 5A2 (EIF5A2) expression as a sponge for microRNA (miR)-140-3p. Finally, the role of RAD51-AS1 was verified by subcutaneous tumorigenesis models. Conclusion: RAD51-AS1 promoted OvCA progression by the regulation of the miR-140-3p/EIF5A2 axis, which illustrated the potential therapeutic target for OvCA.


  • Exposure to silver nanoparticles induces immunological dysfunction in pregnant mice

    by Ling Chen, Haifang Wu, Lulu Le, Pengfei Yang, Fen Fu, Wenting Liu, Hengyi Xu

    The adverse outcomes of silver nanoparticles (AgNPs) on pregnancy have been studied in murine animals. However, the potential toxicity of AgNPs to immune balance, which is essential for maintaining a normal pregnancy, still requires further exploration. Therefore, this study assessed the effect of AgNPs on the immune balance during gestation time. Pregnant mice were given a dose of 1 mg/kg of AgNPs and silver ion on gestation days 3.5 to 9.5 by tail vein injection. Results showed that the AgNPs and silver ion decreased the number of CD4+CD25+ Treg cells which were the important cells in the immune system, thereby disrupting the balance of normal immune tolerance function, activated the inflammatory responses, together with the reductive production of placental immunoregulatory genes, and the expression of inflammatory factors in the placenta in the Ag‐treated groups increased. These effects increased the absorption rate. Furthermore, the inflammatory signaling pathway p38MAPK/AP‐1/MMP‐9 in the placenta was activated, indicating that Ag induced inflammation through this signaling pathway. All results indicated that undesirable pregnancy outcome caused by AgNPs could be happened by stimulating immunological dysfunction. Therefore, the potential risks to embryogenesis exposure to AgNPs that caused immune imbalance should be given sufficient attention.